Le Lézard
Classified in: Health
Subjects: SVY, PET, ANW

Research Confirms the Effectiveness of Phibro Products in Enhancing Dairy Cow Health and Productivity


QUINCY, Ill., June 28, 2018 /PRNewswire/ -- Dairy cattle face immunological stressors every day, on virtually every dairy operation. Environmental factors such as weather, transportation and feed and forage challenges, as well as the changes that occur at dry-off and calving, can have a dramatic and negative impact on herd health and productivity.

Phibro Animal Health Corporation Logo (PRNewsfoto/Phibro Animal Health Corporation)

The impacts of such stressors, and the effects of OmniGen-AF® nutritional specialty product in mitigating them, was a prevalent theme of research presented at the 2018 American Dairy Science Association (ADSA) meeting held this June in Knoxville, Tennessee, to 1,900 dairy industry stakeholders.

Phibro supported research studies conducted by University of Florida ("Effect of heat stress and OmniGen-AF on mammary gland expression and endocrine responses in the dry period"), University of Georgia ("Udder health, milk production and longevity parameters across three OmniGen-AF feeding trials") and California Polytechnic State University ? San Luis Obispo ("Effects of feeding OmniGen-AF on energy metabolism, fecal cortisol metabolites and markers of immunity in overcrowded, lactating Holstein dairy cows").

The effects of OmniGen-AF are measurable through indicators including body temperature, dry matter intake, respiration and milk yields.

Collectively, these studies concluded that OmniGen-AF is an effective strategy in helping to mitigate the effects of stress on dairy herd health and productivity. Conclusions indicated:

"While every dairy, and every cow, is unique, all are susceptible to compromised health and reduced productivity, when faced with stress," says David Kirk, Ph.D., PAS, Phibro Director, Dairy Technical Services, North America. "This research shows that OmniGen-AF helps manage stress and supports healthy immune function, which enables dairy cows to better resist and overcome stressors to achieve their full production potential."

Animate® ? A Closer Look at Subclinical Hypocalcemia

Immunological stressors weren't the only challenges to be evaluated and presented at this year's ADSA meeting.

Phibro Animal Health Corporation also supported a study conducted by S.A. Armstrong, S.S. Bascom, G.A. Holub and D.E. Nuzback to identify factors impacting prevalence of subclinical hypocalcemia on commercial dairies. The group concluded that subclinical hypocalcemia is more predominant in older cows and the prevalence rate is influenced by sampling time. Prevalence of SCH is decreased when cows are fed diets with a prepartum dietary cation-anion difference (DCAD) lower than (more acidogenic) +11mEq/100g DM.

The takeaway: Balancing DCAD diets for transition cows is an effective tool for alleviating subclinical hypocalcemia.

Six additional abstracts were accepted from an experiment examining the effects of feeding a fully acidified prefresh diet using Animate as the sole source of anions with either low or high dietary calcium content (95, M81, M193, M194, T45 and T46). Three treatment diets were fed:

1) CON: A positive DCAD diet with low dietary Ca (0.4% DM)
2) LOW: A fully acidified DCAD diet (urine pH 5.7) with low dietary Ca (0.4% DM)
3) HIGH: A fully acidified DCAD diet (urine pH 5.7) with high dietary Ca (2.0% DM)

Effects of Fully Acidified Close-up Diets and Dietary Calcium Content on In Vitro Innate Immune Function in Transition Dairy Cows
X. Zhang1, K. M. Glosson*2, S. S. Bascom3, Angie D. Rowson3, and J. K. Drackley2

Effects of Fully Acidified Close-up Diets and Dietary Ca Content on Urinary Mineral Excretion in Transition Dairy Cows
K. M. Glosson*1, X. Zhang2, S. S. Bascom3, Angie D. Rowson3, and J. K. Drackley3

Effects of Fully Acidified Close-up Diets and Dietary Calcium Content on Production and Milk Composition of Transition Dairy Cows
K. M. Glosson*1, X. Zhang2, S. S. Bascom3, Angie D. Rowson3, and J. K. Drackley3

Effects of Fully Acidified Close-up Diets and Dietary Calcium Content on Blood Metabolites and Mineral Concentrations of Transition Dairy Cows
K. M. Glosson1*, X. Zhang2, S. S. Bascom3, Angie D. Rowson3, and J. K. Drackley1

Effects of a fully acidified dietary cation-anion difference diet fed at 2 different concentrations of dietary calcium inclusion prepartum on uterine health of Holstein cows after parturition
K.T. Ryan*1, K. Glosson1, X. Zhang2, S. Bascom3, A. Rowson3 and F.C. Cardoso1

Effects of fully acidified dietary cation-anion difference diet fed at 2 different concentrations of dietary calcium inclusion prepartum on inflammatory related blood metabolites
K.T. Ryan*1, K. Glosson1, X. Zhang2, S. Bascom3, A. Rowson3 and F.C. Cardoso1

1Institute of Animal Nutrition, Key Laboratory of Low Carbon Culture and Safety Production in Cattle in Sichuan, Sichuan Agricultural University, Chengdu, Sichuan, P. R. China 611130
2University of Illinois, Department of Animal Sciences, Urbana IL 61801
3Phibro Animal Health Corporation, Teaneck, NJ 07666-6712

For details of these studies, along with a complete list of the research abstracts Phibro supported and presented at ADSA, visit www.adsa.org/2018/Abstract. For additional information on OmniGen-AF, Animate, or other dairy health and nutritional products, contact your local Phibro representative.

About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. For more information, visit pahc.com.

 

SOURCE Phibro Animal Health Corporation


These press releases may also interest you

at 17:21
The Jackson Laboratory (JAX), an independent, nonprofit biomedical research organization, and AbTherx, an innovator in biotechnology, announced a strategic partnership to develop and commercialize cutting-edge tools to expedite antibody discovery and...

at 17:00
Zepp Health Corporation ("Zepp" or the "Company") , a global leader in smart wearables and health technology, today announced that it has received a letter from the New York Stock Exchange (the "NYSE") dated April 30, 2024, notifying Zepp that it is...

at 16:55
Revelation Biosciences, Inc. (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three months ended March...

at 16:55
Maple Counseling has partnered with Saban Community Clinic to launch the Saban Partnership Program, aimed at enhancing access to mental healthcare for underserved communities. This initiative includes the introduction of four bilingual Associate...

at 16:35
Bristol Myers Squibb today announced the Phase 3 CheckMate -73L trial did not meet its primary endpoint of progression-free survival (PFS) in unresectable, locally advanced stage III non-small cell lung cancer (NSCLC). CheckMate -73L evaluated...

at 16:35
Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung...



News published on and distributed by: